Analysis of the burden and variability in the management of NAFLD patients in the clinical practice: unifying the required criteria

Revista Española De Enfermedades Digestivas : Organo Oficial De La Sociedad Española De Patología Digestiva
Yolanda Sánchez-TorrijosManuel Romero-Gómez

Abstract

to assess the prevalence of non-alcoholic fatty liver disease (NAFLD) in the gastroenterology outpatient clinic and describe the use of the resources accordingly. a prospective and observational study of 403 patients seen in the gastroenterology outpatient clinic to rule out liver disease during three randomized months in 2016. The overall prevalence of NAFLD, disease severity, heterogeneity of the final diagnosis, the use of medical resources and their respective cost were analyzed. the main reason for consultation was hypertransaminasemia (42.9%, 173/403), followed by hepatitis C virus (HCV) (28.5%, 115/403). NAFLD was identified as the definitive diagnosis in 29.8% (120/403) of the cohort, 69.2% (83/120) derived by hypertransaminasemia and 24.2% (29/120) by steatosis. Laboratory tests were performed in 96.7% (116/120), abdominal ultrasound in 88.3% (106/120), viral serology in 79.2% (95/120) and autoimmunity in 70% (84/120) of patients with NAFLD. Liver fibrosis was not assessed in 87.5% of cases. In a post-hoc analysis, 12.1% (17/120) had advanced fibrosis by FIB-4. On ultrasound, 65% (73/106) had hepatic steatosis and 15% (17/106) chronic liver disease (significant fibrosis). The mean time for diagnosis was 2.23 ± 0.8 visi...Continue Reading

References

May 13, 2010·Digestive Diseases·Stefano BellentaniGiorgio Bedogni
Jun 21, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Neeraj BhalaJacob George
Nov 22, 2011·BMJ : British Medical Journal·Mariana LazoJeanne M Clark
Sep 10, 2013·Gastroenterología y hepatología·Rocío Gallego-DuránManuel Romero-Gómez
Aug 16, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Mattias EkstedtRolf Hultcrantz
Jun 1, 2012·Journal of Clinical and Experimental Hepatology·Anil Arora, Praveen Sharma
Apr 14, 2015·Gastroenterology·Eduardo Vilar-GomezManuel Romero-Gomez
Jun 9, 2015·World Journal of Hepatology·Fátima Higuera-de la Tijera, Alfredo I Servín-Caamaño
Oct 7, 2016·Annals of Gastroenterology : Quarterly Publication of the Hellenic Society of Gastroenterology·Zannis AlmpanisDina Tiniakos
Jun 10, 2017·World Journal of Hepatology·Yolanda Sanchez-TorrijosManuel Romero-Gómez
Jun 24, 2017·Metabolism: Clinical and Experimental·Isabella RecciaDuncan Spalding
Sep 7, 2017·Gastroenterología y hepatología·Javier AmpueroManuel Romero-Gómez
Feb 17, 2018·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Llorenç CaballeríaPere Ginès
May 20, 2018·Journal of Hepatology·Laura PimpinUNKNOWN EASL HEPAHEALTH Steering Committee
Oct 26, 2018·Alimentary Pharmacology & Therapeutics·Javier AmpueroUNKNOWN HEPAmet Registry

❮ Previous
Next ❯

Citations

Feb 13, 2021·Revista Española De Enfermedades Digestivas : Organo Oficial De La Sociedad Española De Patología Digestiva·Manuel Romero-Gómez, Javier Ampuero

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

© 2022 Meta ULC. All rights reserved